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PECO formulation guidance
A clearly-framed question creates the structure and delineates the approach to defining research objectives, conducting systematic reviews and developing health guidance [1, 2] . To assess the association between exposures and outcomes, including in the field of nutrition, environmental and occupational health, the concept of defining the Population (including animal species), Exposure, Comparator, and Outcomes (PECO) as pillars of the question is increasingly accepted [3, 4] . Thus, the PECO defines the objectives of the review or guideline. Furthermore, the PECO informs the study design or inclusion and exclusion criteria for a review, as well as facilitating the interpretation of the directness of the findings based on how well the actual research findings represent the original question.
Previously, we have recognized the importance of PECOs for directing the assessments of benefits and harms, identification of exposures as risk factors or within risk assessments, and evaluation of the impact of interventions that prevent or mitigate an exposure or risk [3] ; however, in debating PECO questions in our work, we found no guiding framework for operationalizing the PECO approach and the types of PECO questions researchers and decisionmakers can answer. We identified only limited indirect guidance based on the development of Population, Intervention, Comparator, and Outcomes (PICO) questions where the general concept originated [1] . The Cochrane Collaboration emphasizes the importance of a wellformulated research question to guide an intervention review and provides clarity about the individual PICO components [5] ; however, a review of 313 research studies reported that over half (54%) of the studies did not report on the four PICO components [6] . 113  114  115  116  117  118  119  120  121  122  123  124  125  126  127  128  129  130  131  132  133  134  135  136  137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168 In environmental, public and occupational health research, specific challenges exist with identifying the exposure and comparator within the PECO. In fact, in these fields there are fundamental differences to formulating questions about interventions and comparators in the PICO framework [1]. The Cochrane Handbook, widely recognized as reference guide for systematic reviews, does not specifically address the development of questions for reviews of exposures [5] . Other organizations have reported adapting PICO to PECO for studies of unintentional exposure [7] [8] [9] . For example, the Collaboration for Environmental Evidence recognizes the transition from PICO to PECO for questions about the effect of an exposure [7] .
The Navigation Guide, the National Toxicology Program's Office of Health Assessment and Translation, the U.S. Environmental Protection Agency's (EPA) Integrated Risk Information System (IRIS) and the European Food and Safety Association (EFSA) emphasize the role of the PECO question to guide the systematic review process for questions about exposures [8] [9] [10] .
EFSA also proposes a back-calculation of PECO elements to define an exposure (if the effect on the outcome is known among a determined population) [10] . Typically review authors have used approaches to PECO questions that are reflective of two of the scenarios that we will present, specifically cases where the research question aims to evaluate whether an exposure is associated with a health outcome(s). However, the PECO can also be focused in ways that can make the systematic review perhaps better suited to inform decision-makers and these are illustrated in three scenarios we will present. These latter PECO approaches are seldom used; in part this may be due to the fact that a fully developed framework for operationalizing the development of PECO questions does not exist.
Given the lack of such guidance, research studies and systematic reviews often fail to explicitly state the PECO question. On the other hand, when reviews do start with a well-developed PECO question, the purpose of the research is more clearly defined for the reader. For example, a recent systematic review broadly explored whether or not exposure to serum or plasma perfluorooctanoic acid (PFOA) among humans before or during pregnancy is associated with fetal growth [11] . The authors reported that a 1 ng/mL increase in serum or plasma perfluorooctanoic acid (PFOA) is associated with an 18.9 g decrease in birth weight. The review appropriately specified the population, exposure, comparator and outcome and it focused on exploring the presence or absence of an association. This approach is often chosen when little is known about the exposure and its potential relationship to an outcome. An alternative way to characterize with the impact of PFOA on health outcomes could better inform decision-makers.
For instance, one might ask which exposure level would lead to a dangerous decline in birth weight or negative health outcomes in this population. If pursuing this strategy, evidence would be needed to define the outcome of interest; in this example, although challenging, the protocol would need to qualify the level of decline in birth weight that is considered harmful. Neither of the two former approaches is superior or inferior; they simply describe different research questions or phases in exploring the impact of exposures on outcomes. In fact, the general approach to phrasing PECO questions will depend on a number of factors, including a) the context; and b) what might be known about the effects of an exposure on an outcome at a given time. However, because of the dependence on the research and decision-making context, clarifying these aspects for the purpose of developing a PECO is crucial.
To address these issues, we developed a framework to formulate PECO questions that includes five paradigmatic scenarios. These scenarios are common for researchers conducting individual studies and authors of systematic reviews. Our framework proposes solutions with examples (related to the topic of hearing impairment) to facilitate the creation of PECO questions with a 225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240  241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280 strong focus on the 'E' and 'C' domains (Table 1) . This is because we consider defining the population (including animal populations) and outcomes as more straightforward given their relation to the existing PICO literature. We attempted to support our framework by examples.
Furthermore, for practical reasons our primary focus is on environmental health and we drew on selected examples from these fields; however, these scenarios are relevant to other disciplines, including broader public health questions and nutrition. Since the exploration of the existence of an association between an exposure and a comparator is the building block for any further evaluation, we will describe that scenario first. We follow with scenarios in which this evaluation has been done or, for some scenarios, the decision-making context may be known. As stated above, none of the approaches is superior to another and they are influenced by the context of what is known as we will lay out in this brief article.
Insert Table 1 .
Quantifying the exposure
Research to understand and quantify the exposure is needed to properly address scenarios 2 to 5 and formulate the PECO questions for them. In our first scenario, we describe what typically precedes those scenarios when little or nothing is known about the relationship between an exposure and outcome. Research addressing this scenario can provide information on the mean levels of exposure, ranges of exposures, and the nature of the association with the health outcome. In fact, for many organizations these are the most common questions asked. We will then present the remaining four scenarios with the assumption that research informing scenario 1 is available. 283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336 To implement the framework, researchers can utilize a number of sources to inform and facilitate the quantification of an exposure and, specifically, to define the criteria for the comparator. We refer to this in many examples as a cut-off value. We use the term cut-off to broadly to refer to thresholds, levels, durations, means, medians, or ranges of exposure. In this commentary, our examples are informed by previously published primary research or systematic reviews and government identified thresholds (e.g. Occupational Safety Health Administration [OSHA]); however, other sources may include current legislation or a level which is considered to produce a minimally-important change.
PECO Scenario 1
The first scenario facilitates the identification of a comparison when little or nothing is known about the association between exposure and the outcome, including the nature of the relationship.
This PECO, as stated one of the most common situations in environmental health, aims to explore the impact of different levels of exposure on health outcomes and the nature of the relationship. The comparator includes the entire range of exposures (e.g. an incremental increase in exposure). Here, all comparators are predefined by what the observed data will show. The objective may be to define whether or not there is an association between the exposure and health outcome and, if there is an association, to identify the nature of the relationship, e.g., linear, logarithmic or u-shaped. For example, we present a summary of the results from two systematic reviews wherein this explorative PECO scenario leads to differing findings. In the first, a systematic review examined the association between 10 ng/mL increments of exposure to vitamin D and a range of health outcomes, including prostate cancer. The review reported no association between the 1,25(OH)2D biomarker to measure vitamin D with development of prostate cancer [12] . The second review examined the association between short-term exposure 337  338  339  340  341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360  361  362  363  364  365  366  367  368  369  370  371  372  373  374  375  376  377  378  379  380  381  382  383  384  385  386  387  388  389  390  391  392 to particulate mass with aerodynamic diameter less than 2.5µm (PM 2.5 ) and suggested a positive linear relationship with mortality from stroke [13] .
In conjunction with Table 1 , we provide additional examples to illustrate these scenarios using the topic of hearing impairment. To explore postnatal hearing impairment as a result of prenatal noise exposure, one may choose to examine an incremental increase in decibel (dB) exposure.
Research suggests a linear dose-response relationship between the level of noise (i.e. dBs), duration of exposure, and health outcome of hearing impairment [14] ; however, little is known about the effect of prenatal noise exposure on newborn hearing impairment [15] . Since there is insufficient information to isolate a specific comparison when examining prenatal noise exposure, we would develop a PECO that explores the association between incremental increase in exposure and hearing impairment. The size of the increments of the comparator may be informed by existing rationale or, if no evidence exists, they may require a more arbitrary identification. When developing a scenario about prenatal noise exposure, we present a hypothetical PECO question to reflect this situation, understanding that the 'E' and the 'C' could represent different values or smaller increments to measure change in the outcomes. For this example, we derived the incremental increase from the OSHA's Standardized Threshold Shift for occupational noise exposure of 10 dB [16] . 393  394  395  396  397  398  399  400  401  402  403  404  405  406  407  408  409  410  411  412  413  414  415  416  417  418  419  420  421  422  423  424  425  426  427  428  429  430  431  432  433  434  435  436  437  438  439  440  441  442  443  444  445  446  447  448   PECO Scenario 2 In the second scenario, we are interested in comparing health effects of different exposure levels but either do not know naturally occurring exposure levels or are unsure about which cut-offs to choose. This scenario is often a direct consequence of scenario 1 and may be addressed in the same systematic review as scenario 1 from which it would follow. Scientists often present data in ordinal groups (e.g. quartiles) in such situations. For example, we previously reported the effects of different levels of antioxidant blood and serum levels on pulmonary function and respiratory health [17] [18] [19] . The choice for the exposure and comparator in a systematic review may therefore be based on measures of distribution of the exposure in the included studies (e.g., central tendency values; highest versus lowest exposure groups such tertiles, quartiles, or quintiles).
Ideally, the included studies describe the rationale for presentation of the exposure distribution to 449  450  451  452  453  454  455  456  457  458  459  460  461  462  463  464  465  466  467  468  469  470  471  472  473  474  475  476  477  478  479  480  481  482  483  484  485  486  487  488  489  490  491  492  493  494  495  496  497  498  499  500  501  502  503  504 In addition, this second scenario could be informed by baseline risk data from a population-level study that allows specifying the exposure of the comparison. For example, by using the disaggregated population-weighted mean concentrations of PM 2.5 [20] .
PECO Scenario 3
Our third scenario addresses formulating a PECO question in which we might have information about a certain exposure level for a population of interest but want to compare that to the impact of a different level of exposure on a certain health outcome. In this situation the mean cut-offs from an external or general population (from other research) may serve as the comparator. For example, we may be interested in comparing the impact of exposure to PM 2.5 from one country to either a different country or a global mean. To do this we could use the data reporting PM 2.5 levels on the outcome of airflow obstruction from a nationally-representative survey in China as our exposure and outcome of interest. The comparator could then be informed by either the mean concentration of PM 2.5 levels in a different country or the global population-weighted mean concentration of PM 2.5 levels [20] . The systematic review would address the following PECO: "In people exposed to particulate matter, what is the impact of levels of exposure identified in China compared to other countries or the global mean on airflow obstruction?" Of course, the ensuing analyses would have to carefully account for potential covariates or confounders.
A second example focuses on the impact of noise exposure among commercial pilots on hearing impairment exposure-level estimates from a cohort study conducted in Sweden [21] . To compare the risk of hearing impairment among commercial pilots with other occupations or the general population, we could conduct a systematic review of the effects on hearing impairment using a references of exposure levels from other occupations. 505  506  507  508  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544  545  546  547  548  549  550  551  552  553  554  555  556  557  558 
PECO Scenario 4
In the fourth scenario, we may have sufficient information about the exposure and outcome to quantify a dose-response relation. Specifying the exposure and comparator will include using existing exposure cut-offs (e.g., thresholds, levels, durations, means, medians, or ranges of exposure) associated with the health outcomes of interest. For example, we may want to explore long-term exposure to occupational noise levels greater than 80 dB, which increase the risk of hearing impairment compared to lower levels [22] . The difference between this and the next scenario lies in the exploration (i.e. comparison) of what an intervention can achieve and outcomes that are associated with defined exposure levels.
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PECO Scenario 5
The fifth scenario typically occurs when there is evidence suggesting an association between an exposure and the outcome, such as the research suggesting a dose-response relationship between the level of noise and health outcome of hearing impairment referenced previously [14] (based on a PECO following scenario 1, table 1). If a decision-maker is interested in a specific exposure cut-off or intervention to mitigate the exposure through known interventions, they will ask systematic reviewers to conduct a review using the PECO framework that appropriately describes the health effects of exposures that are achievable or realistic in relation to a comparator.
A policy maker may want to know, in the absence of evidence evaluating the impact of an intervention or in the context of new interventions for which high certainty evidence is available, what the potential impact of that intervention is on health effects. As direct evidence evaluating the intervention is not available, the exposure cut-offs in the PECO question would be informed by the implementation of an intervention (e.g. the potential introduction of a novel street surface that can reduce noise levels by 20 dB) compared to not implementing the intervention. Note that this will still only provide indirect evidence for the effects of the intervention but can be helpful 
Summary and conclusions
Formulating informative questions is a prerequisite for conducting an evidence synthesis in systematic reviews. The PECO approach to question formulation supports the conduct of a systematic review, including formulating search and eligibility criteria, presenting outcomes, and the wording in guidelines of final recommendations. We found little guidance about how to formulate questions that deal with unintentional exposures and, therefore, developed a framework based on existing examples and in-depth discussion that will help those designing research studies and authors of systematic reviews dealing with all populations and outcomes.
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Among newborns, what is the incremental effect of 10 dB increase during gestation on postnatal hearing impairment?
2. Evaluate the effect of an exposure cut-off on health outcomes, when the cut-off can be informed iteratively by the results of the systematic review.
Use cut-offs defined based on distribution in the studies identified in the systematic review.
Among newborns, what is the effect of the highest dB exposure compared to the lowest dB exposure (e.g. identified tertiles, quartiles, or quintiles) during pregnancy on postnatal hearing impairment?
3. Evaluate the association between an exposure cut-off and a comparison cut-off, when the cut-offs can be identified or are known from other populations. 
